A phase 2 trial of high-dose Allovectin-7 in patients with advanced metastatic melanoma

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 7509-7509 ◽  
Author(s):  
J. Richards ◽  
A. Y. Bedikian ◽  
R. Gonzalez ◽  
M. B. Atkins ◽  
E. D. Whitman ◽  
...  
Keyword(s):  
Metastatic Melanoma ◽  
High Dose ◽  
Phase 2 ◽  
Phase 2 Trial

scholarly journals A Phase 2 Trial of Bevacizumab and High-dose Interferon Alpha 2B in Metastatic Melanoma

2011 ◽  
Vol 34 (6) ◽  
pp. 509-515 ◽  
Author(s):  
Valerie P. Grignol ◽  
Thomas Olencki ◽  
Kiran Relekar ◽  
Cynthia Taylor ◽  
Amanda Kibler ◽  
...  
Keyword(s):  
Metastatic Melanoma ◽  
Interferon Alpha ◽  
High Dose ◽  
Phase 2 ◽  
Interferon Alpha 2B ◽  
Phase 2 Trial ◽  
High Dose Interferon

scholarly journals A phase 2 trial of sequential temozolomide chemotherapy followed by high-dose interleukin 2 immunotherapy for metastatic melanoma

Cancer ◽  
2008 ◽  
Vol 113 (7) ◽  
pp. 1632-1640 ◽  
Author(s):  
Ahmad A. Tarhini ◽  
John M. Kirkwood ◽  
William E. Gooding ◽  
Stergios Moschos ◽  
Sanjiv S. Agarwala
Keyword(s):  
Metastatic Melanoma ◽  
Interleukin 2 ◽  
High Dose ◽  
Phase 2 ◽  
Phase 2 Trial ◽  
Temozolomide Chemotherapy

A phase 2 trial of high-dose Allovectin-7 in patients with advanced metastatic melanoma

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 7509-7509
Author(s):  
J. Richards ◽  
A. Y. Bedikian ◽  
R. Gonzalez ◽  
M. B. Atkins ◽  
E. D. Whitman ◽  
...  
Keyword(s):  
Metastatic Melanoma ◽  
High Dose ◽  
Phase 2 ◽  
Phase 2 Trial

scholarly journals A phase 2 trial exploring the effects of high-dose (10,000 IU/day) vitamin D3in breast cancer patients with bone metastases

Cancer ◽  
2010 ◽  
Vol 116 (2) ◽  
pp. 284-291 ◽  
Author(s):  
Eitan Amir ◽  
Christine E. Simmons ◽  
Orit C. Freedman ◽  
George Dranitsaris ◽  
David E. C. Cole ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Bone Metastases ◽  
Cancer Patients ◽  
High Dose ◽  
Phase 2 ◽  
Breast Cancer Patients ◽  
Phase 2 Trial

OFATUMUMAB WITH IVAC FOR DLBCL PATIENTS WHO FAILED R-CHOP AND WERE NOT CANDIDATES FOR HIGH-DOSE THERAPY AND ASCT - PHASE 2 TRIAL OF THE POLISH LYMPHOMA RESEARCH GROUP (PLRG-8)

2019 ◽  
Vol 37 ◽  
pp. 436-437
Author(s):  
E. Paszkiewicz-Kozik ◽  
W. Michalski ◽  
M. Taszner ◽  
W. Knopińska-Posłuszny ◽  
M. Mordak-Domagała ◽  
...  
Keyword(s):  
Research Group ◽  
High Dose ◽  
Phase 2 ◽  
High Dose Therapy ◽  
Dose Therapy ◽  
Phase 2 Trial
Sign in / Sign up

Export Citation Format

Share Document